Home RxNorm 1665362 24 HR aspirin 162.5 MG Extended Release Oral Capsule [Durlaza] Drug identity information. FDA.report links public drug records from RxNav, DailyMed, FDA NDC, Drugs@FDA, and related public sources where available. This page is informational only and is not medical, prescribing, or regulatory advice.
RxCUI 1665362
RxNorm name 24 HR aspirin 162.5 MG Extended Release Oral Capsule [Durlaza]
Display name DURLAZA XR (Oral Pill)
Full name 24 HR aspirin 162.5 MG Extended Release Oral Capsule [Durlaza]
Term type SBD
Status Active
Strength 162.5 mg
Dose form 24 HR XR Cap
Route Oral Pill
Updated 2026-10-20 20:51:02 RxNorm Status History#
Status Active
Source RXNORM
Current YES
Release start 102015
Active start 102015
Multiple ingredient NO
Branded YES Ingredients And Strength# Ingredient, Strength, Base table Ingredient Strength Base Basis of strength aspirin 162.5 MG / 1 EACH aspirin aspirin
Derived Ingredient Concepts# Ingredient, RxCUI table Ingredient RxCUI aspirin 1191
RxNav Current And Historical NDCs# RxNav current and historical NDC rows page 1 of 1 · 2 matching rows.
NDC11, Source, Active table NDC11 Source Active 58487000101 rxnav_ndcs yes 58487000102 rxnav_historical
UNII Substances# UNII substance links page 1 of 1 · 0 matching rows.
No records found.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings# unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.
Set ID, RxNorm mappings, Terms table Set ID RxNorm mappings Terms SPL version Label Effective 4c2a1403-3862-1efd-0a91-444989222b37 Durlaza 162.5 MG 24HR Extended Release Oral Capsule [PSN] · 24 HR aspirin 162.5 MG Extended Release Oral Capsule [Durlaza] [SBD] · 24 HR ASA 162.5 MG Extended Release Oral Capsule [Durlaza] [SY] · Durlaza 162.5 MG 24HR Extended Release Oral Capsule [SY] 4 6 These highlights do not include all the information needed to use DURLAZA ™ safely and effectively. See full prescribing information for DURLAZA. DURLAZA (aspirin) Extended Release Capsules, for oral use Initial U.S. Approval:2015 20150925
Recently Linked DailyMed Labels# Set ID, Title, Manufacturer table Set ID Title Manufacturer Effective 4c2a1403-3862-1efd-0a91-444989222b37 These highlights do not include all the information needed to use DURLAZA ™ safely and effectively. See full prescribing information for DURLAZA. DURLAZA (aspirin) Extended Release Capsules, for oral use Initial U.S. Approval:2015 New Haven Pharmaceuticals, Inc. | PATHEON PHARMACEUTICALS INC. 20150925
Properties# Category, Property, Value table Category Property Value ATTRIBUTES AVAILABLE_STRENGTH 162.5 MG ATTRIBUTES GENERAL_CARDINALITY SINGLE ATTRIBUTES HUMAN_DRUG US ATTRIBUTES QUANTITY 24 HR ATTRIBUTES RXNAV_HUMAN_DRUG US NAMES Prescribable Synonym Durlaza 162.5 MG 24HR Extended Release Oral Capsule SOURCES Source Gold Standard Alchemy